UMPC pays $5M for Monroeville medical building
UPMC paid $5 million for an office building in Monroeville that it has been leasing for several years.
The building, at 400 Oxford Drive, is adjacent to the Monroeville Mall and a UPMC imaging center, and houses a cancer center, a sleep center and physician practices.
UPMC bought the building from L&M Associates, a partnership owned by Mark Mason, vice chairman of Downtown-based Oxford Development Co., and a trust established by the late Edward J. Lewis, who died in 2006 and was a founder of Oxford Development. The deal closed Dec. 3.
UPMC, the largest hospital system in Western Pennsylvania, has leased the space since 2008, when the sleep center moved in, spokeswoman Susan Manko said. The cancer center opened there in 2010 and UPMC added the doctor offices this year, she said.
“With the growing demand for UPMC services in this community, it made more sense for us to purchase this building rather than continue renting,” she said.
Alex Nixon is a staff writer for Trib Total Media. He can be reached at 412-320-7928 or email@example.com.
TribLive commenting policy
You are solely responsible for your comments and by using TribLive.com you agree to our Terms of Service.
We moderate comments. Our goal is to provide substantive commentary for a general readership. By screening submissions, we provide a space where readers can share intelligent and informed commentary that enhances the quality of our news and information.
While most comments will be posted if they are on-topic and not abusive, moderating decisions are subjective. We will make them as carefully and consistently as we can. Because of the volume of reader comments, we cannot review individual moderation decisions with readers.
We value thoughtful comments representing a range of views that make their point quickly and politely. We make an effort to protect discussions from repeated comments â either by the same reader or different readers.
We follow the same standards for taste as the daily newspaper. A few things we won't tolerate: personal attacks, obscenity, vulgarity, profanity (including expletives and letters followed by dashes), commercial promotion, impersonations, incoherence, proselytizing and SHOUTING. Don't include URLs to Web sites.
We do not edit comments. They are either approved or deleted. We reserve the right to edit a comment that is quoted or excerpted in an article. In this case, we may fix spelling and punctuation.
We welcome strong opinions and criticism of our work, but we don't want comments to become bogged down with discussions of our policies and we will moderate accordingly.
We appreciate it when readers and people quoted in articles or blog posts point out errors of fact or emphasis and will investigate all assertions. But these suggestions should be sent via e-mail. To avoid distracting other readers, we won't publish comments that suggest a correction. Instead, corrections will be made in a blog post or in an article.